Patients Discontinuing Anti-Obesity Injections Gain Back Weight Four Times Faster Compared to Those on Conventional Diets

Fresh analysis indicates that patients who stop using popular weight-loss injections like Wegovy and Mounjaro tend to recover lost weight far faster than those who halt traditional lifestyle programs.

Findings released in a leading medical journal points out that while obese people often shed about a fifth of their body weight while undergoing treatment, the mass returns at an average rate of nearly a kilo each month once they quit.

"Users using such drugs need to be aware of the potential of fast rebound weight gain when the medication concludes," warns expert Dr. Susan Jebb.

That rate of regain implies a reversion to starting mass within about one and a half years.

Comparing Approaches

The analysis, which looked at 37 of trials involving thousands of patients, compared the outcomes of these new drugs with older methods.

Scientists point out that people who lose weight through lifestyle changes alone generally have a slower weight regain—approximately 0.1 kg a month—once they finish.

The Reason for the Rapid Regain

Doctors believe the way of the injections accounts for the amplified weight return.

GLP-1 drugs imitate a natural hormone called glucagon-like peptide-1, which helps regulate appetite.

"Artificially providing GLP-1 concentrations several times higher than the body's typical production could lead to the body to generate a reduced amount of its own natural GLP-1, and may also diminish responsiveness to its effects," explained Dr. Adam Collins, a nutrition specialist.

"Withdrawal of this GLP-1 'fix' results in hunger is uncontrolled, making binge eating much more probable."

An Ongoing Disease?

Medical guidelines recommend the jabs for individuals with weight-linked health risks, alongside prescribed diet and exercise modifications.

A number of clinicians contend that, due to the high risk of weight regain, the therapy should be considered life-long.

This perspective is reinforced by pharmaceutical companies, who say that the findings "highlight the long-term character of excess weight," similar to managing conditions like high blood pressure.

User Testimonies

People who have stopped the jabs explain a powerful resurgence of hunger.

"It was like something flipping and you're instantly starving," said a patient.

This difficulty is worsened if patients have not established sustainable lifestyle or habit modifications during treatment.

Growing Adoption

Figures show that millions of people in the UK have tried weight-loss jabs in the last 12 months, with desire being substantial.

• Use is more common among women compared to men.
• The middle-aged demographic shows the highest level of interest.
• A large proportion access the medications through private prescriptions rather than the NHS.

In conclusion, clinicians caution that while the jabs are powerful agents for weight loss, they are not a permanent solution and lasting health benefits hinges on ongoing lifestyle support.